Bicycle Therapeutics plc (BCYC) Misses Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BCYC Hot Sheet
Join SI Premium – FREE
Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q2 EPS of ($0.90), $0.06 worse than the analyst estimate of ($0.84). Revenue for the quarter came in at $4.38 million versus the consensus estimate of $3.69 million.
For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Datadog stock tumbles 19% despite earnings beat
- Grainger (GWW) Tops Q3 EPS by 87c ; Offers Guidance
- Medline Inc. (MDLN) Reports Q3 EPS of $0.44
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
